• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

OMRF is an independent, nonprofit biomedical research institute dedicated to discoveries that make a difference.

  • About
    • General Information
    • Disease Research
    • Education & Outreach
    • Events
    • Careers
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • News Releases
    • Publications
    • On Your Health
    • Bodywork
  • Patients
    • Anti-Aging Studies
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Disease
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Tax Credit
    • Planned Giving
    • Vehicle Donations
    • Why We Give
    • Your Gift at Work
    • Donor Recognition
    • Contact
Home - OMRF News - Archives for glioma

glioma

OMRF brain tumor drug receives rare disease designations from the FDA

September 2, 2020

The drug treats fast-growing, deadly brain cancers with no effective treatment.

Filed Under: News, Technology Ventures News Tagged With: 007, administration, approval, bob, Bob Floyd, brain cancer, cancer, center, childhood, diffuse intrinsic pontine glioma, dipg, drug, FDA, Floyd, glioblastoma, glioma, Oblato, Oklahoma Medical Research Foundation, okn, OKN-007, OKN007, OMRF, OUHSC, pediatric, rare pediatric disease designation, Rheal, robert, rpdd, scientist-news, stephenson, Towner

Biotech company acquires OMRF brain cancer drug

February 15, 2016

Agreement will expand clinical trials of glioblastoma drug

Filed Under: News Tagged With: brain cancer, brain tumor, cancer, clinical trial, glioblastoma, glioma, Gtree, GtreeBNT, investigational drug, Manu Nair, Oblato, OKN-007, pharmaceuticals, Rheal, scientist-news, Towner

Biomarkers help doctors decide how to treat brain cancers

September 10, 2013

OMRF’s biomarker discoveries could bring new therapies for beating gliomas.

Filed Under: Diseases, Featured News, News Tagged With: angiogenesis, antibody therapy, brain cancer, brain tumor, GAMMA, glioblastoma, glioma, Jonathan, jonathan wren, MRI, Randy Jensen, Rheal, rheal towner, scientist-news, Towner, Wren

OMRF brain cancer drug enters clinical trials at OU cancer center

August 7, 2013

OMRF, Stephenson Cancer Center begin tests of experimental compound

Filed Under: Diseases, News, Research News Tagged With: brain cancer, cancer, cancer center, Charles and Peggy Stephenson Cancer Center, clinical trials, drug study, drug trial, experimental treatment, glioblastoma, glioma, ou, Rheal, rheal towner, scientist-news, Stephenson Cancer Center, Towner, university of oklahoma

Attacking cancer on multiple fronts

May 7, 2013

Cutting off avenues for growth is key to killing tumors.

Filed Under: Diseases, Featured News, News, Research News Tagged With: brain cancer, brain tumor, glioblastoma, glioma, Huntsman Cancer Center, OKN007, OMRF, Rheal, rheal towner, robert floyd, scientist-news, Towner

Cancer

For many cancers, the odds of survival now are better than ever and going up.

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Before Footer

EEO/AA Employer/Vet/Disabled

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Intranet
Facebook Twitter Instagram Linkedin

Subscribe to OMRF News
  • Contact
  • Careers
  • Donor Privacy
  • Intranet
OMRF Logo
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 NE 13th St.
Oklahoma City, OK 73104
(405) 271-6673
Charity navigatorUnited WayGive Smart OKCTop Workplace